Effect of citrate concentration in specimen collection tubes on the International Normalized Ratio.
Danielson CF, Davis K, Jones G, Benson J, Arney K, Martin J
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of citrate concentration (3.2% versus 3.8%) and type of coagulometer used on PT and INR in plasma from patients on warfarin anticoagulant therapy. All plasma was frozen immediately and stored at -70 degrees C or lower. A subset of specimens was shipped on dry ice to an alternate laboratory for analysis on a different coagulometer (MLA 1000). The two laboratories thawed specimens in 37 degrees C water baths 30 min prior to analysis.
Summary of Findings
For both coagulometers, the mean INR calculated from PT measured in plasma from 3.2% citrate tubes was significantly lower than the mean INR calculated from PT measured in plasma from 3.8% citrate tubes (p<0.001). In several cases, while specimens from one tube fell within the therapeutic range, the duplicate specimen with the alternate citrate concentration had an INR indicating an increased risk for bleeding or thromboembolism. The authors recommend that for PT testing, 3.2% citrate tubes be used rather than 3.8% citrate tubes. No statistical comparison between the two coagulometers is presented, however, the MLA 1000 coagulometer measured higher mean INRs for both 3.2% and 3.8% citrate specimens than the ACL 300, but differences may also be attributable to storage or transport effects.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
Not specifiedPlatforms
MorphologyHematology/ auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateMultiple concentrations evaluatedStorage Between site transportation method Not transportedUnspecified transport methodHematology/ auto analyzer Specific Technology platform ACL 300 coagulometerMLA 1000